| For: | Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, Akkoc N. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World J Gastroenterol 2008; 14(18): 2912-2914 [PMID: 18473420 DOI: 10.3748/wjg.14.2912] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2912.htm |
| Number | Citing Articles |
| 1 |
Rasha H. Bassyouni, Reham A. Dwedar, Eman M. Ezzat, Raghda N. Marzaban, Maha Hamdy Nassr, Laila Rashid. Elevated Cytomegalovirus and Epstein-Barr virus burden in rheumatoid arthritis: A true pathogenic role or just a coincidence. The Egyptian Rheumatologist 2019; 41(4) doi: 10.1016/j.ejr.2019.03.003
|
| 2 |
Seo Young Kim, Daniel H. Solomon. Tumor necrosis factor blockade and the risk of viral infection. Nature Reviews Rheumatology 2010; 6(3) doi: 10.1038/nrrheum.2009.279
|
| 3 |
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Cytomegalovirus subacute thyroiditis in a patient treated by infliximab for psoriatic arthritis. Joint Bone Spine 2016; 83(1) doi: 10.1016/j.jbspin.2015.06.001
|
| 4 |
M. J. SHALE, C. H. SEOW, C. S. COFFIN, G. G. KAPLAN, R. PANACCIONE, S. GHOSH. Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2010; 31(1) doi: 10.1111/j.1365-2036.2009.04112.x
|
| 5 |
Anzelika Rubina, Mihil Patel, Katie Nightingale, Martin Potts, Ceri A. Fielding, Simon Kollnberger, Betty Lau, Kristin Ladell, Kelly L. Miners, Jenna Nichols, Luis Nobre, Dawn Roberts, Terrence M. Trinca, Jason P. Twohig, Virginia-Maria Vlahava, Andrew J. Davison, David A. Price, Peter Tomasec, Gavin W. G. Wilkinson, Michael P. Weekes, Richard J. Stanton, Eddie C. Y. Wang. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences 2023; 120(33) doi: 10.1073/pnas.2303155120
|
| 6 |
Manola Comar, Serena Delbue, Loredana Lepore, Stefano Martelossi, Oriano Radillo, Luca Ronfani, Pierlanfranco D'Agaro, Pasquale Ferrante. Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2. Journal of Medical Virology 2013; 85(4) doi: 10.1002/jmv.23525
|
| 7 |
S. Domm, J. Cinatl, U. Mrowietz. The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature. British Journal of Dermatology 2008; 159(6) doi: 10.1111/j.1365-2133.2008.08851.x
|
| 8 |
|
| 9 |
Dora Y. Ho, Kyle Enriquez, Ashrit Multani. Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics of North America 2020; 34(2) doi: 10.1016/j.idc.2020.02.006
|
| 10 |
Cloé Comarmond, Bertrand Wechsler, Patrice Cacoub, David Saadoun. Approaches to Immunosuppression in Behçet‘s Disease. Immunotherapy 2013; 5(7) doi: 10.2217/imt.13.66
|
| 11 |
Renée M. Marchioni Beery, Joshua R. Korzenik. Treatment of Inflammatory Bowel Disease with Biologics. 2018; doi: 10.1007/978-3-319-60276-9_12
|
| 12 |
Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri, Petros P. Sfikakis. Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients. Seminars in Arthritis and Rheumatism 2011; 41(1) doi: 10.1016/j.semarthrit.2010.09.002
|
| 13 |
J. Correia, A. Campar, C. Ferrão, S. Silva, C. Vasconcelos. Infection and Autoimmunity. 2015; doi: 10.1016/B978-0-444-63269-2.00055-6
|
| 14 |
Justina Wei Lynn Tan, Hwee Siew Howe, Hiok Hee Chng. Ovarian Vein Thrombosis in Behçet Disease. JCR: Journal of Clinical Rheumatology 2012; 18(2) doi: 10.1097/RHU.0b013e318247c187
|
| 15 |
Gulen Hatemi, Hasan Yazici. Behçet’s syndrome and micro-organisms. Best Practice & Research Clinical Rheumatology 2011; 25(3) doi: 10.1016/j.berh.2011.05.002
|
| 16 |
Muhammed Sherid, Eli D. Ehrenpreis. Types of Colitis Based on Histology. Disease-a-Month 2011; 57(9) doi: 10.1016/j.disamonth.2011.05.004
|
| 17 |
Peter C. Taylor, Nehal Narayan. Oxford Textbook of Rheumatoid Arthritis. 2020; doi: 10.1093/med/9780198831433.003.0031
|
| 18 |
Christian Michaux, Philippe Morlat, Fabrice Bonnet. Infections à cytomégalovirus et autres viroses du groupe herpès au cours des maladies systémiques. La Presse Médicale 2010; 39(1) doi: 10.1016/j.lpm.2009.04.005
|
| 19 |
Moe Kato, Shin Lee, Tetsuji Morishita, Kei Fujita, Atsushi Tagami, Hiroshi Araki, Jun-ichi Sugihara. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab. Journal of Infection and Chemotherapy 2022; 28(6) doi: 10.1016/j.jiac.2022.01.018
|
| 20 |
Ondrej Hradsky, Ivana Copova, Kristyna Zarubova, Marianna Durilova, Jiri Nevoral, Miroslav Maminak, Petr Hubacek, Jiri Bronsky. Seroprevalence of Epstein–Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(11) doi: 10.1007/s10620-015-3764-z
|
| 21 |
Fatemeh Dabbagh, Afshin Borhani Haghighi, Younes Ghasemi. Behcet’s disease: from heat shock proteins to infections. Asian Biomedicine 2014; 8(2) doi: 10.5372/1905-7415.0802.274
|
| 22 |
R. Cavallo. The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy. Clinical Microbiology and Infection 2011; 17(12) doi: 10.1111/j.1469-0691.2011.03678.x
|
| 23 |
Daniel Sánchez-Cano, José Luis Callejas-Rubio, Ricardo Ruiz-Villaverde, Raquel Ríos-Fernández, Norberto Ortego-Centeno. Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis. Mediators of Inflammation 2013; 2013 doi: 10.1155/2013/286857
|
| 24 |
I. Marie, E. Guglielmino. Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFα. La Revue de Médecine Interne 2010; 31(5) doi: 10.1016/j.revmed.2009.04.010
|
| 25 |
Felix Braun, Nadja Rifaie, Dieter C. Broering, Matthias Behrend. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 2010; 32 doi: 10.1016/S0378-6080(10)32037-X
|
| 26 |
M. J. Shale. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. British Medical Bulletin 2009; 92(1) doi: 10.1093/bmb/ldp036
|
| 27 |
Saied Ghorbani, Davod Javanmard, Seyed Jalal Kiani, Ahmad Tavakoli, Somayeh Sadat Moochani, Seyed Hamid Reza Monavari. No evidence of Human Cytomegalovirus infection among Behcet's Patients. Iranian Journal of Medical Microbiology 2020; 14(2) doi: 10.30699/ijmm.14.2.133
|
| 28 |
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub, David Saadoun. Biotherapies in Behçet's disease. Autoimmunity Reviews 2014; 13(7) doi: 10.1016/j.autrev.2014.01.056
|
| 29 |
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 2018; 16(10) doi: 10.1080/14787210.2018.1521270
|
| 30 |
Pierre Charles, Felix Ackermann, Gaelle Burdy, Olivier Blétry, Jacques Leport, Jean Emmanuel Kahn. Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab. Scandinavian Journal of Gastroenterology 2010; 45(4) doi: 10.3109/00365520903583871
|
| 31 |
Haoting Zhan, Linlin Cheng, Haolong Li, Yongmei Liu, Yuan Huang, Xiaomeng Li, Songxin Yan, Yongzhe Li. Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet’s disease by leveraging gene microarray data. Immunologic Research 2023; 71(6) doi: 10.1007/s12026-023-09398-w
|
| 32 |
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Thyroïdite subaiguë de De Quervain à cytomégalovirus chez un patient traité par infliximab pour un rhumatisme psoriasique. Revue du Rhumatisme 2015; 82(5) doi: 10.1016/j.rhum.2015.01.002
|
| 33 |
C. Comarmond, B. Wechsler, P. Cacoub, D. Saadoun. Traitement de la maladie de Behçet. La Revue de Médecine Interne 2014; 35(2) doi: 10.1016/j.revmed.2013.12.003
|
| 34 |
Mohsen Moghoofei, Hamid Pajavand, Razieh Shahbazi, Marzieh Rezaei, Elahe Taki. The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease. Journal of Clinical Laboratory Analysis 2026; 40(1) doi: 10.1002/jcla.70133
|